OR WAIT null SECS
Taking a brief status check on the biologics supply chain and any impact on scale up operations.
In speaking with Suzanne Aldington, senior principal scientist, Downstream Processing, Biologics, and Lucas Lin, senior principal scientist, Global Process Development Implementation, Biologics, both at Lonza, BioPharm International® took a pulse on the supply chain lifeline for biologics in the post-pandemic setting. Discussion revolved around any impact the current state of the supply chain may be imparting on scale-up activities in downstream bioprocessing.
Feliza Mirasol is the science editor for BioPharm International.
eBook: Manufacturing and Facilities 2023
When referring to this article, please cite it as Mirasol, F. A Look at Supply Chain for Scale Up. BioPharm International’s Manufacturing and Facilities 2023 eBook. November 2023.